Endocrinology & metabolism
Hormones & metabolism clinical trials
Diabetes, obesity, thyroid, and other conditions of the body’s hormones and metabolism. We’re tracking 7,616 recruiting studies in this area right now.
By phase
- Not applicable5,344
- Phase 2606
- Phase 1557
- Phase 3418
- Phase 4318
- Phase 1/Phase 2288
- Phase 2/Phase 385
Top conditions
- Obesity618
- Ovarian Cancer337
- Pancreatic Cancer287
- Type 2 Diabetes275
- Diabetes192
- Diabetes Mellitus182
- Diabetes Mellitus, Type 2171
- Hypertension138
- Type 1 Diabetes131
- Metabolic Syndrome127
- Obesity & Overweight125
- Breast Cancer111
- Cardiovascular Diseases105
- Overweight105
- Amyotrophic Lateral Sclerosis102
- Pancreas Cancer91
- Colorectal Cancer90
- Thyroid Cancer87
Leading sponsors
- Mayo Clinic87
- Novo Nordisk A/S64
- University of Colorado, Denver53
- Assistance Publique - Hôpitaux de Paris52
- M.D. Anderson Cancer Center42
- Eli Lilly and Company41
- Massachusetts General Hospital41
- IRCCS Azienda Ospedaliero-Universitaria di Bologna40
- National Taiwan University Hospital40
- Johns Hopkins University38
Where studies are running
- California521
- Maryland180
- Alabama176
- Arizona170
- Florida166
- Texas159
- Massachusetts150
- New York144
- Colorado115
- Pennsylvania113
Recruiting studies7,616 total
- NCT07259317RecruitingPhase 2
Relacorilant plus chemo for metastatic pancreatic cancer
This trial tests adding a drug called relacorilant to standard chemotherapy (nab-paclitaxel and gemcitabine) for people with pancreatic cancer that has spread. The goal is to see if this combination works better than chemo alone.
Scottsdale, ArizonaAges 18 years+ - NCT07255209RecruitingPhase 3
A study of IBI362 for Chinese teens with obesity or overweight
This trial tests a new medicine, IBI362, to help Chinese adolescents lose weight. It may be an option if you are 12 to 17 years old and have obesity or overweight with a related health condition.
Hangzhou, ZhejiangAges 12–18 - NCT07252232RecruitingPhase 3
A pill to prevent pancreatic cancer recurrence after surgery
This trial tests an experimental daily pill, daraxonrasib, in people with pancreatic cancer that has been surgically removed. It’s for those who also had chemotherapy and have a specific DNA change called a RAS mutation. The goal is to see if the pill helps prevent the cancer from coming back.
Phoenix, ArizonaAges 18 years+ - NCT07256925Recruiting
Malnutrition screening for clinic patients
This trial is testing a simple screening tool to identify malnutrition risk in adults visiting hospital clinics. Participating could help researchers find better ways to spot nutrition problems early and connect you with help.
Sarıçam, AdanaAges 18 years+ - NCT06881511Recruiting
Betaine for autoimmune gastritis
This study tests whether betaine hydrochloride, a supplement that helps with digestion, can improve symptoms in people with autoimmune gastritis. It is for adults who have been diagnosed with this condition and have high gastrin levels or a related stomach history.
Hangzhou, ZhejiangAges 18–80 - NCT06824376Recruiting
Acupuncture for high uric acid without gout
This trial tests if manual acupuncture can safely lower uric acid in people who have high levels but have never had a gout attack. It aims to find a drug-free way to manage hyperuricemia before it causes joint problems.
Wuhan, HubeiAges 18 years+ - NCT06894784RecruitingPhase 3
Combining two diabetes drugs with an automated insulin pump
This trial tests if adding semaglutide and empagliflozin to your automated insulin delivery system (like a smart pump) can improve blood sugar control for adults with type 1 diabetes. It may help with both glucose levels and weight management.
Montreal, QuebecAges 18 years+ - NCT06902597Recruiting
Sarcopenia and nerve damage in type 1 diabetes: a pilot study
This study looks at whether muscle loss (sarcopenia) is related to diabetic nerve damage in adults with type 1 diabetes. If you join, you will help researchers understand this connection better.
Rome, LazioAges 50–80 - NCT07255911Recruiting
Comparing two medicines for ovulation in PCOS
This study tests if adding cabergoline to letrozole works better than letrozole alone to help women with PCOS ovulate. It may help participants who have not had success with standard treatments.
Dhaka, ShahbagAges 18–35 - NCT07258199Enrolling by invitation
TACE treatment for large, benign thyroid nodules
This trial tests whether a minimally invasive treatment called TACE (injecting small particles into blood vessels) can shrink large, benign thyroid nodules. It may be an option for people who want to avoid surgery but have nodules causing mild discomfort.
BeijingAges 18–80 - NCT07255469Recruiting
Fluid response test in children after heart surgery
This trial tests how well the body responds to a fluid bolus in children who have just had heart surgery. It uses blood gas tests and maybe an ultrasound to guide treatment.
Bron, FranceAges birth–15 years - NCT07257523RecruitingPhase 2
Carbon ion radiation for frail patients with pancreatic cancer
This trial tests a precise type of radiation called carbon ion radiotherapy for people with pancreatic cancer who are too frail for surgery or standard chemotherapy. It aims to see if this treatment can help control the cancer with fewer side effects.
SeoulAges 20 years+ - NCT07254364Recruiting
Wearable sensor study for glucose monitoring
This study tests a wearable device that may measure blood sugar without needles. It could help people manage their diet and health more easily.
College Station, TexasAges 18–90 - NCT07253389Recruiting
Comparing two TIPS techniques to prevent variceal rebleeding in cirrhosis
This trial tests a slightly smaller TIPS stent (underdilated) against the standard size to see which is better at preventing another variceal bleed in people with cirrhosis and liver scarring. It aims to find the safest way to lower pressure in the veins while reducing side effects.
Xi'an, ShaanxiAges 18–75 - NCT07254689Recruiting
Food for Health: A diabetes nutrition study for Native American elders
This study tests if a food program can help older Native American adults on the Flathead Reservation who have diabetes or are at risk for it. It looks at how better nutrition affects health.
Arlee, MontanaAges 55 years+ - NCT07258563Recruiting
Can a special diet prevent taste changes from chemo?
This study looks at whether a special diet can help prevent taste changes during chemotherapy. It is for people with certain cancers who are about to start treatment.
AmsterdamAges 18–70 - NCT07255807Recruiting
Understanding insulin resistance in healthy adults
This study will look at how insulin resistance works in the body by studying healthy adults. You may help researchers find new ways to understand and treat conditions like diabetes.
CopenhagenAges 25–55 - NCT07251257Recruiting
Continuous glucose monitor study for seafarers with diabetes
This trial tests if wearing a continuous glucose monitor (CGM) for 12 months helps seafarers on insulin better manage their blood sugar levels while at sea. You'll also use an app to log readings and activities.
Guildford, SurreyAges 18 years+ - NCT07253155Enrolling by invitation
Probiotics for preventing gut symptoms in overweight adults
This study tests whether taking probiotics can help prevent stomach and gut discomfort in people who are overweight or have obesity. You may be eligible if you are at a certain weight and age, eat a balanced diet, and do not have chronic gut issues.
ColeraineAges 18 years+ - NCT07254065Recruiting
Preventing obesity early with telehealth support
This study tests a telehealth program to help prevent obesity in pregnant women. It offers support and education through video calls to promote healthy habits.
New Hyde Park, New YorkAges 18 years+ - NCT07255274Recruiting
Sleep help for teens with overweight or obesity
This study tests whether a behavior-based sleep program can help teenagers aged 13–17 who are overweight or have obesity and also have sleep problems. The goal is to see if improving sleep can help with weight management.
CovilhaAges 13–17 - NCT07256769Recruiting
Vitamin K, D-chiro inositol and α-lactalbumin for bone health
This trial tests a combination of vitamin K, D-chiro inositol, and α-lactalbumin to help maintain bone strength in women with breast cancer who are on hormone therapy and have low vitamin D. It aims to see if these supplements improve bone health while you take a standard bone medication (alendronate).
Latina, ItalyAges 35–70 - NCT07255300Recruiting
Fasting-mimicking diet for aging and health in adults
This study tests whether a special low-calorie diet that mimics fasting can help reduce risk factors for aging and age-related diseases. It is for healthy adults aged 30 to 65 who are willing to follow this diet for several days each month.
Varapodio, Calabria, ItalyAges Any age - NCT07249775Recruiting
Study of new drug FID-022 for pancreatic cancer
This trial tests a new study drug called FID-022 for people with pancreatic cancer. It is a first-in-human study, meaning it is the first time this drug is being tested in people, and researchers want to see if it is safe and how it works.
Tampa, FloridaAges 18 years+
Common questions
- How many hormones & metabolism clinical trials are recruiting?
- Clin2 is tracking 7,616 recruiting endocrinology & metabolism studies from the U.S. registry right now, out of 11,939 we cover in this area in total.
- What does “Hormones & metabolism” cover here?
- Diabetes, obesity, thyroid, and other conditions of the body’s hormones and metabolism. We group each study into hormones & metabolism based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a hormones & metabolism trial near me?
- Use the search to filter hormones & metabolism studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.